| Date Filed | Type | Description |
| 06/06/2018 |
4
| KOVEN ANDREW I (President & Chief Business Off) has filed a Form 4 on Aralez Pharmaceuticals Inc.|
Txns:
| Sold 156,573 shares
@ $0.3742, valued at
$58.6k
|
|
| 05/16/2018 |
4
| KOVEN ANDREW I (President & Chief Business Off) has filed a Form 4 on Aralez Pharmaceuticals Inc.|
Txns:
| Sold 13,964 shares
@ $0.52, valued at
$7.3k
|
|
| 05/16/2018 |
4
| Tursi James Patrick (Chief Medical Officer) has filed a Form 4 on Aralez Pharmaceuticals Inc.|
Txns:
| Sold 9,348 shares
@ $0.5222, valued at
$4.9k
|
|
| 03/21/2018 |
4
| Tursi James Patrick (Chief Medical Officer) has filed a Form 4 on Aralez Pharmaceuticals Inc.|
Txns:
| Sold 5,950 shares
@ $1.7, valued at
$10.1k
|
|
| 03/21/2018 |
4
| Trachtenberg Eric (GC, CCO & Secretary) has filed a Form 4 on Aralez Pharmaceuticals Inc.|
Txns:
| Sold 3,471 shares
@ $1.7, valued at
$5.9k
|
|
| 03/21/2018 |
4
| KOVEN ANDREW I (President & Chief Business Off) has filed a Form 4 on Aralez Pharmaceuticals Inc.|
Txns:
| Sold 9,739 shares
@ $1.7, valued at
$16.6k
|
|
| 03/21/2018 |
4
| Glickman Mark A (Chief Commercial Officer) has filed a Form 4 on Aralez Pharmaceuticals Inc.|
Txns:
| Sold 5,725 shares
@ $1.7, valued at
$9.7k
|
|
| 03/19/2018 |
4
| Kaseta Michael (CFO) has filed a Form 4 on Aralez Pharmaceuticals Inc.|
Txns:
| Granted 12,500 shares
@ $0
Granted 25,000 options to buy
@ $1.75, valued at
$43.8k
|
|
| 12/12/2017 |
4
| Kirsch Arthur S (Director) has filed a Form 4 on Aralez Pharmaceuticals Inc.|
Txns:
| Bought 50,000 shares
@ $1.4707, valued at
$73.5k
|
|
| 12/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/04/2017 |
3
| Kaseta Michael (Interim CFO) has filed a Form 3 on Aralez Pharmaceuticals Inc. |
| 10/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2017 |
4
| Trachtenberg Eric (GC, CCO & Secretary) has filed a Form 4 on Aralez Pharmaceuticals Inc.|
Txns:
| Sold 7,720 shares
@ $1.33, valued at
$10.3k
|
|
| 06/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/12/2017 |
4
| KOVEN ANDREW I (President & CBO) has filed a Form 4 on Aralez Pharmaceuticals Inc.|
Txns:
| Granted 109,190 shares
@ $0
Granted 126,158 options to buy
@ $1.56, valued at
$196.8k
|
|
| 05/12/2017 |
4
| thrasher francis martin (Director) has filed a Form 4 on Aralez Pharmaceuticals Inc.|
Txns:
| Granted 7,500 shares
@ $0
Granted 15,000 options to buy
@ $1.56, valued at
$23.4k
|
|
| 05/12/2017 |
4
| RUDNICK SETH (Director) has filed a Form 4 on Aralez Pharmaceuticals Inc.|
Txns:
| Granted 7,500 shares
@ $0
Granted 15,000 options to buy
@ $1.56, valued at
$23.4k
|
|
| 05/12/2017 |
4
| LEE KENNETH B JR (Director) has filed a Form 4 on Aralez Pharmaceuticals Inc.|
Txns:
| Granted 7,500 shares
@ $0
Granted 15,000 options to buy
@ $1.56, valued at
$23.4k
|
|
| 05/12/2017 |
4
| Harris Robert Paul (Director) has filed a Form 4 on Aralez Pharmaceuticals Inc.|
Txns:
| Granted 7,500 shares
@ $0
Granted 15,000 options to buy
@ $1.56, valued at
$23.4k
|
|
| 05/12/2017 |
4
| Kirsch Arthur S (Director) has filed a Form 4 on Aralez Pharmaceuticals Inc.|
Txns:
| Granted 7,500 shares
@ $0
Granted 15,000 options to buy
@ $1.56, valued at
$23.4k
|
|
| 05/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/25/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/22/2017 |
4
| Charles Scott J (CFO) has filed a Form 4 on Aralez Pharmaceuticals Inc.|
Txns:
| Sold 5,205 shares
@ $2.41, valued at
$12.5k
|
|
|